THE NICKLES GROUP, LLC for JOHNSON & JOHNSON SERVICES, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Monitored the American Jobs Plan, as it relates to corporate and international taxes
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues related to maternal health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to Medicare coverage of vaccines. Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues related to maternal health. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Budget/Appropriations BUD
Monitored S.Con.Res.14, FY 2022 Budget Resolution, as it relates to drug pricing and S.2428, The False Claims Amendments Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Consumer Issues/Safety/Products CSP
S. 1425, Stop STALLING Act, S. 1428, Preserve Access to Affordable Generics and Biosimilars Act, S. 1388, Prescription Pricing for the People Act of 2021, and S. 1435, Affordable Prescriptions for Patients Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF CHOUDHRY New | U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern |
Government Issues GOV
Issues related to Medicare coverage of vaccines. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19, the Lower Costs, More Cures Act. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.